JMJacob M. Miller

Jacob M. Miller

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jacob M. Miller has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dfm1 promotes Ste24-dependent translocon quality control

    by James A Avaala, Sophia L Owutey, Connor G Bailey, Kathryn L Alexander, Karen E Alexander, Melissa Palackel, Travis S Beckett, Katrina A Procuniar, Kyle A Richards, Kelsey A Woodruff, et al.

    Proteins stalled during endoplasmic reticulum translocation clog Sec61 channels and require translocon quality control (TQC) mechanisms for clearance. Genetic screens implicated the derlin Dfm1 in TQC; however, its mechanistic role remained unclear. Using engineered and disease-relevant translocon-clogging substrates in Saccharomyces cerevisiae, we show Dfm1 functions in the Ste24-dependent branch of TQC, but not Hrd1- or Ltn1-dependent pathways. Loss of DFM1 increased accumulation and toxicity of translocon-clogging proteins. Increased dosage of wild type or catalytically inactive Hrd1 or Ste24 rescued toxicity, supporting a non-enzymatic buffering function for these factors in TQC. These findings identify Dfm1 as a key TQC factor whose critical role in clearing clogged translocons can be suppressed in multiple ways. Our results suggest enhancing TQC may protect cells from proteotoxic stress caused by disease-relevant translocon-clogging substrates, with potential implications for pancreatic β-cell dysfunction in diabetes.

  • Open Access

    Loss of transcriptional regulator of phospholipid biosynthesis alters post-translational modification of Sec61 translocon beta subunit Sbh1 in Saccharomyces cerevisiae

    by Jacob M. Miller, Mary E. Tragesser-Tiña, Samantha M. Turk, Eric M. Rubenstein

    We recently discovered that disrupting phospholipid biosynthesis by eliminating the Ino2/4 transcriptional regulator impairs endoplasmic reticulum (ER)-associated degradation (ERAD) in Saccharomyces cerevisiae , but the mechanism is unclear. Phosphatidylcholine deficiency has been reported to accelerate degradation of Sec61 translocon beta subunit Sbh1 and ERAD cofactor Cue1. Here, we found that, unlike targeted phosphatidylcholine depletion, INO4 deletion does not destabilize Sbh1 or Cue1. However, we observed altered electrophoretic mobility of Sbh1 in ino4 Δ yeast, consistent with phospholipid-responsive post-translational modification. A better understanding of the molecular consequences of disrupted lipid homeostasis could lead to enhanced treatments for conditions associated with perturbed lipid biosynthesis.

  • Open Access

    Lipid biosynthesis perturbation impairs endoplasmic reticulum–associated degradation

    by Samantha M. Turk, Christopher J. Indovina, Jacob M. Miller, Danielle L. Overton, Avery M. Runnebohm, Cade J. Orchard, Mary E. Tragesser-Tiña, Samantha K. Gosser, Ellen M. Doss, Kyle A. Richards, et al.